Financhill
Back

Citius Pharmaceuticals Quote, Financials, Valuation and Earnings

Sell
28

CTXR
Citius Pharmaceuticals

Last Price:
0.65
Seasonality Move:
-21.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Citius Pharmaceuticals Price Quote

$0.65
+0.00 (+-2.62%)
(Updated: May 18, 2024 at 5:40 AM ET)

Citius Pharmaceuticals Key Stats

Sell
28
Citius Pharmaceuticals (CTXR) is a Sell

Day range:
$0.64 - $0.67
52-week range:
$0.60 - $1.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.48%

Volume:
895.1K
Avg. volume:
1.3M
1-year change:
-41.05%
Market cap:
$117.1M
Revenue:
$0
EPS:
$-0.24

How Much Does Citius Pharmaceuticals Make?

Data Unavailable

Is Citius Pharmaceuticals Growing As A Company?

Data Unavailable

Citius Pharmaceuticals Stock Price Performance

What Is Citius Pharmaceuticals 52-Week High & Low?

Citius Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Citius Pharmaceuticals?

Is Citius Pharmaceuticals Cash Flow Positive?

  • What Is CTXR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$30.3M
  • What Is Citius Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Citius Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Citius Pharmaceuticals Return On Invested Capital

Data Unavailable

Citius Pharmaceuticals Earnings Date & Stock Price

Citius Pharmaceuticals Competitors

Citius Pharmaceuticals Dividend Yield

Data Unavailable

Citius Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.67%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.00
Upside from Last Price: 516.9%

Major Shareholders

  • How many CTXR shares are owned by institutional investors?
    46.9M CTXR shares are owned by institutional investors
  • How many CTXR shares are owned by insiders?
    12.3M CTXR shares are owned by insiders